Intermittent prednisolone and autoantibodies to GAD65 in juvenile neuronal ceroid lipofuscinosis

Neurology. 2008 Apr 1;70(14):1218-20. doi: 10.1212/01.wnl.0000307753.88839.29.
No abstract available

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Age Factors
  • Autoantibodies / blood*
  • Biomarkers / blood
  • Brain / immunology
  • Brain / metabolism
  • Brain / physiopathology
  • Child
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Female
  • Glucocorticoids / administration & dosage
  • Glutamate Decarboxylase / immunology*
  • Humans
  • Intelligence / drug effects
  • Intelligence / physiology
  • Male
  • Movement Disorders / drug therapy
  • Movement Disorders / genetics
  • Movement Disorders / immunology
  • Neuronal Ceroid-Lipofuscinoses / blood
  • Neuronal Ceroid-Lipofuscinoses / drug therapy*
  • Neuronal Ceroid-Lipofuscinoses / immunology*
  • Prednisolone / administration & dosage*
  • Recovery of Function / drug effects
  • Recovery of Function / immunology
  • Treatment Outcome
  • gamma-Aminobutyric Acid / biosynthesis

Substances

  • Autoantibodies
  • Biomarkers
  • Glucocorticoids
  • gamma-Aminobutyric Acid
  • Prednisolone
  • Glutamate Decarboxylase
  • glutamate decarboxylase 2